Literature DB >> 29655274

Granulocyte colony-stimulating factor-producing melanoma treated with the combination of dabrafenib and trametinib.

T Minowa1, J Kato1, T Hida1, K Horimoto1, S Sato1, M Sawada1, H Takahashi1, H Uhara1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29655274     DOI： 10.1111/ijd.14004

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  2 in total

1.  Multiple Phenotypic Conversion in Malignant Melanoma: Obtainment of Granulocyte Colony-Stimulating Factor-Producing Ability during the Intermission of Nivolumab Therapy.

Authors:  Satomi Chujo; Yoshimasa Nobeyama; Akihiko Asahina; Munenari Itoh
Journal:  Case Rep Oncol       Date:  2022-05-30

2.  Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy.

Authors:  Thilo Gambichler; E Stockfleth; L Susok
Journal:  J Immunother Cancer       Date:  2018-10-30       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.